Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
MGC Pharmaceuticals (AU:MXC)
ASX:MXC
MGC Pharmaceuticals (MXC) Share Price & Analysis
0 Followers
MXC Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.41 - AU$13.00
Previous CloseAU$0.68
Volume163.00
Average Volume (3M)43.11K
Market Cap
AU$3.08M
Enterprise ValueAU$4.89M
Total Cash (Recent Filing)AU$1.89M
Total Debt (Recent Filing)AU$4.35M
Price to Earnings (P/E)>-0.1
Beta0.41
Next Earnings
Feb 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.07
Shares Outstanding35,430,491
10 Day Avg. Volume1,492
30 Day Avg. Volume43,108
Standard Deviation0.25
R-Squared0.16
Alpha0.00774
Financial Highlights & Ratios
Price to Book (P/B)-139.36
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)-23.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MXC FAQ
What was MGC Pharmaceuticals’s price range in the past 12 months?
MGC Pharmaceuticals lowest share price was AU$0.41 and its highest was AU$13.00 in the past 12 months.
What is MGC Pharmaceuticals’s market cap?
Currently, no data Available
When is MGC Pharmaceuticals’s upcoming earnings report date?
MGC Pharmaceuticals’s upcoming earnings report date is Feb 26, 2024 which is in 88 days.
How were MGC Pharmaceuticals’s earnings last quarter?
MGC Pharmaceuticals released its earnings results on Aug 31, 2023. The company reported -AU$3.27 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$3.27.
Is MGC Pharmaceuticals overvalued?
According to Wall Street analysts MGC Pharmaceuticals’s price is currently Overvalued.
Does MGC Pharmaceuticals pay dividends?
MGC Pharmaceuticals does not currently pay dividends.
What is MGC Pharmaceuticals’s EPS estimate?
MGC Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MGC Pharmaceuticals have?
MGC Pharmaceuticals has 4,427,968 shares outstanding.
What happened to MGC Pharmaceuticals’s price movement after its last earnings report?
MGC Pharmaceuticals reported an EPS of -AU$3.27 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.882%.
Which hedge fund is a major shareholder of MGC Pharmaceuticals?
Currently, no hedge funds are holding shares in AU:MXC
---
MGC Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
-95.66%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-47.92%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
MGC Pharmaceuticals
MGC Pharmaceuticals Ltd is a European-based specialist Medical Cannabis company, in Phytocannabinoid-based medicine within the biopharmaceutical industry. The company's principal business goal is to produces and supply quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.
---
ACADIA Pharmaceuticals
―
Aptose Biosciences
―
Arcturus Therapeutics
―
Axsome Therapeutics
―
MGC Pharmaceuticals
―
---